Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: MarketLine (a Datamonitor Company)
$175.00
Provider: Wright Reports
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Dainippon Sumitomo Pharma raises consolidated full-year outlook for FY 2014


Friday, 4 Apr 2014 02:00am EDT 

Dainippon Sumitomo Pharma Co Ltd:Says the company increased the consolidated full-year outlook for revenue to 387,000 million yen from 385,000 million yen for the fiscal year ended March 2014.Sees an increased operating profit forecast to 42,000 million yen from 35,000 million yen.Sees an increased ordinary profit forecast to 41,000 million yen from 34,000 million yen.Sees an increased net profit forecast to 20,000 million yen from 17,000 million yen.Sees an increased earnings per share to 50.34 yen from 42.79 yen.FY 2014 revenues of 381.29 billion yen, reported net profit of 18.80 billion yen – Thomson Reuters I/B/E/S.Comments the steady growth of business in North America, as well as cost down are the main reasons for the forecast. 

Related Company News

Company Quote

1257.0
-10.0 -0.79%
1 Aug 2014